How is it that Sandoz is becoming another Abbott for us? Sure, they are not as bad as Abbott, but Sandoz controls a much larger Vitaros market than Canada. To wit: Germany, Austria, Belgium, Luxemburg, the Netherlands, Denmark, Finland, Iceland, Norway, Sweden and Switzerland, Malaysia, Indonesia, the Philippines, Thailand, Taiwan, Vietnam, Hong Kong and Singapore. So a Sandoz slow up for whatever reason has a huge impact on the potential sales trajectory.
What is particularly irritating is that Sandoz has aggressively tied up a lot of Vitaros marketing territory but has not aggressively marketed. Just what we don't need.
Just venting.
|
